SEC Form 4 · accession 0001493152-16-014598
Ernexa Therapeutics Inc. · ERNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ram Krishnan
Officer — CEO · Director
Period of report
Nov 4, 2016
Accepted (ET)
Nov 7, 2016 · 7:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000748592
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 4, 2016 | A | 30,000 | $6.64 | A | 35,900 | D |
Table II — derivative securities
No Table II lines on this filing.